BOOST Pharma presents at the 3rd ATMP Mini-Symposium in Lund
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
Final Dosing in BOOSTB4 Trial
BOOST Pharma awarded RPD
BOOST Pharma at OIFE’s Annual Educational Webinar
Orphan Drug Designation in the US
Leadership and clinical update
Orphan Drug Designation for OI